Abstract |
The purpose of this study is visual evaluation of the distribution of I-123 iomazenil in the brains of patients with various types of mental disorder and to examine whether chronic administration of a clinical dose of benzodiazepine (BZ) affects the binding of I-123 iomazenil to BZ receptors (BZR). The subjects were 10 patients with mental disorders (3 males and 7 females) with a mean age of 26.8 yrs (range 19-39 yrs). Four of 10 patients were administered BZ for over 3 months and the other six were free of BZ for over one month. The SPECT images were obtained at 5-25 min (early) and 170-190 min (delayed), after the bolus i.v. injection of 167 MBq of I-123 iomazenil, with a triple-head gamma camera. The images were visually evaluated and the washout ratios of each region were calculated. In visual analysis, abnormalities were recognized in 5 patients on the delaye SPECT. The abnormalities were recognized more frequently in the superior frontal lobe. The washout ratio was higher in the BZ (+) patient group than in the BZ (-) patient group. I-123 iomazenil is useful, because the SPECT image with I-123 iomazenil reflects the distribution of BZR on the brain and provides the different information from that obtained with perfusion SPECT, X-ray CT or MRI. The rapid washout of I-123 iomazenil from the brains of BZ (+) patients suggests that chronic administration of a clinical dose of BZ affects the binding of I-123 iomazenil to BZR.
|
Authors | Y Nakabeppu, M Nakajo, T Naruo, Y Obo, S Nozoe, M Takigawa, S Tsuchimochi, A Tani, H Tanaka |
Journal | Annals of nuclear medicine
(Ann Nucl Med)
Vol. 11
Issue 4
Pg. 339-44
(Nov 1997)
ISSN: 0914-7187 [Print] Japan |
PMID | 9460528
(Publication Type: Journal Article)
|
Chemical References |
- Anti-Anxiety Agents
- Iodine Radioisotopes
- Radiopharmaceuticals
- Flumazenil
- iomazenil
|
Topics |
- Adult
- Anti-Anxiety Agents
(therapeutic use)
- Anxiety Disorders
(diagnostic imaging, drug therapy, metabolism)
- Brain
(diagnostic imaging, drug effects, metabolism)
- Female
- Flumazenil
(analogs & derivatives, pharmacokinetics)
- Humans
- Iodine Radioisotopes
(pharmacokinetics)
- Male
- Mental Disorders
(diagnostic imaging, drug therapy, metabolism)
- Radiopharmaceuticals
(pharmacokinetics)
- Tomography, Emission-Computed, Single-Photon
(methods)
|